NCT04571567 2022-04-11
A Study to Evaluate the Efficacy and Safety of Secukinumab in Adult Patients With Skin Types IV-VI With Moderate to Severe Plaque Psoriasis
Icahn School of Medicine at Mount Sinai
Phase 4 Completed
Icahn School of Medicine at Mount Sinai
Novartis
Novartis
Novartis